Latest Trials

EudraCT Number: 2021-002686-18 Sponsor Protocol Number: EP0162 Start Date:
Sponsor Name: UCB Biopharma SRL
Full Title: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Outpatient, Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Olde...
Medical condition: Treatment of stereotypical prolonged seizure
Disease: Version SOC Term Classification Code Term Level
20.0 10029205 - Nervous system disorders 10076333 Prolonged seizure LLT
Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: DE (Ongoing) IT (Ongoing) FR (Ongoing) HU (Ongoing) CZ (Ongoing) ES (Ongoing) PL (Ongoing) BG (Ongoing)
Trial results: (No results available)
EudraCT Number: 2010-020386-24 Sponsor Protocol Number: TRO19622CLEQ1275-1 Start Date:
Sponsor Name: TROPHOS SA
Full Title: Phase II, multicenter, randomized, adaptive, double-blind, placebo controlled study to assess safety and efficacy of olesoxime (TRO19622) in 3-25 year old Spinal Muscular Atrophy (SMA) patients.
Medical condition: Spinal Muscular Atrophy (type 2 or type 3 non ambulant patients aged 3-25 years)
Disease: Version SOC Term Classification Code Term Level
12.1 10041582 Spinal muscular atrophy LLT
Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: FR (Ongoing) NL (Completed) BE (Completed) DE (Completed) IT (Completed) GB (Completed)
Trial results: View results
EudraCT Number: 2012-004586-41 Sponsor Protocol Number: CHUBX2012/16 Start Date:
Sponsor Name: CHU de Bordeaux
Full Title: Cognitive remediation in Attention Deficit Disorder with or without Hyperactivity (ADHD) children : Comparison between three therapeutic strategies : cognitive remediation with a virtual classroom ...
Medical condition: Attention Deficit Disorder with or without Hyperactivity
Disease: Version SOC Term Classification Code Term Level
16.0 100000004873 10003730 Attention deficit and disruptive behaviour disorders HLT
Population Age: Children, Under 18 Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)
EudraCT Number: 2021-002637-42 Sponsor Protocol Number: EP0165 Start Date:
Sponsor Name: UCB Biopharma SRL
Full Title: An Open-Label, Multicenter, Outpatient Extension Study to Evaluate the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Se...
Medical condition: Treatment of stereotypical prolonged seizure
Disease: Version SOC Term Classification Code Term Level
20.0 10029205 - Nervous system disorders 10076333 Prolonged seizure LLT
Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: DE (Ongoing) ES (Ongoing) IT (Ongoing) FR (Not Authorised) HU (Ongoing) CZ (Ongoing) PL (Ongoing) BG (Ongoing)
Trial results: (No results available)
EudraCT Number: 2009-017267-41 Sponsor Protocol Number: CQAV680A2201E1 Start Date:
Sponsor Name: Novartis Pharma Services AG
Full Title: A randomized, double-blind, parallel group study to compare the pharmacodynamics/efficacy, safety and pharmacokinetics of QAV680 versus placebo in patients with moderate persistent asthma
Medical condition: Moderate persistent asthma
Disease: Version SOC Term Classification Code Term Level
9.1 10003553 Asthma LLT
Population Age: Adults Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2009-014768-21 Sponsor Protocol Number: TUD-TEMDS1-042 Start Date:
Sponsor Name: Dresden Technical University
Full Title: Treatment of MDS patients with single agent temsirolimus – a pilot study
Medical condition: Myelodysplastic Syndromes (MDS) (20 IPSS LOW+INT-1 and 20 IPSS INT-2+HIGH or proliferating CMML)
Disease: Version SOC Term Classification Code Term Level
14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10028533 Myelodysplastic syndrome PT
Population Age: Adults Gender: Male, Female
Trial protocol: DE (Prematurely Ended)
Trial results: View results
EudraCT Number: 2010-021792-81 Sponsor Protocol Number: 2010-12 Start Date:
Sponsor Name: ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE
Full Title: SFCE-Metro 01 : Etude de phase II de chimiothérapie métronomique associant celecoxib-methotrexate-vinblastine-cyclophosphamide chez les enfants porteurs d’une tumeur solide en rechute ou en progre...
Medical condition: children and adolescents with relapsed or progressing solid tumours.
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)
EudraCT Number: 2005-002270-29 Sponsor Protocol Number: IN 0401 INT Start Date:
Sponsor Name: LEO Pharma A/S
Full Title: Safety profile of innohep versus subcutaneous unfractionated Heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis
Medical condition: Treatment of acute deep vein thrombosis in elderly patients with impaired renal function
Disease: Version SOC Term Classification Code Term Level
6.1 10051055 LLT
Population Age: Elderly Gender: Male, Female
Trial protocol: DE (Prematurely Ended) ES (Completed) DK (Prematurely Ended) BE (Completed) CZ (Prematurely Ended) BG (Prematurely Ended)
Trial results: View results
EudraCT Number: 2019-004511-31 Sponsor Protocol Number: cASPerCF_2007_OPBG_2019 Start Date:
Sponsor Name: Bambino Gesù Children's Hospital
Full Title: Prospective validation and clinical evaluation of a new posaconazole dosing regimen for children and adolescents with cystic fibrosis and Aspergillus infection.
Medical condition: Cystic Fibrosis and Aspergillus Infection
Disease: Version SOC Term Classification Code Term Level
20.0 100000004862 10003488 Aspergillosis LLT
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: GB (GB - no longer in EU/EEA) IT (Prematurely Ended) PT (Prematurely Ended) GR (Prematurely Ended) FR (Prematurely Ended) NL (Prematurely Ended) IE (Prematurely Ended) DE (Prematurely Ended) ES (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2012-003139-50 Sponsor Protocol Number: Maxillo1 Start Date:
Sponsor Name: University of Bergen, Faculty of medicin and dentistry, Dep. of Clinical Dentistry
Full Title: International, multicenter phase II uncontrolled prospective clinical trial: Jaw bone reconstruction using a combination of biomaterial and autologous mesenchymal stem cells prior to dental impla...
Medical condition: Men and women aged 18 years or more requiring jaw bone reconstruction prior to dental implant placement based on clinical and radiological examinations (CBCT Cone beam CT imaging). Areas suitable ...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: NO (Ongoing)
Trial results: (No results available)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe